Authors:
Tsukiyama, T
Ishida, N
Shirane, M
Minamishima, YA
Hatakeyama, S
Kitagawa, M
Nakayama, K
Nakayama, K
Citation: T. Tsukiyama et al., Down-regulation of p27(Kip1) expression is required for development and function of T cells, J IMMUNOL, 166(1), 2001, pp. 304-312
Citation: M. Shirane et K. Nakamura, Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP, BRAIN RES, 916(1-2), 2001, pp. 211-221
Citation: K. Nakamura et al., Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats, BRAIN RES, 897(1-2), 2001, pp. 82-92
Authors:
Shirane, M
Hashimoto, Y
Yamada, H
Yokoyama, H
Citation: M. Shirane et al., A compact optical sampling measurement system using mode-locked laser-diode modules, IEEE PHOTON, 12(11), 2000, pp. 1537-1539
Citation: M. Yamamoto et al., The results of radiation therapy for glottic carcinoma: Prognostic significance of tumor size in laryngoscopic findings, ONCOL REP, 7(6), 2000, pp. 1275-1277
Authors:
Nakayama, K
Nagahama, H
Minamishima, YA
Matsumoto, M
Nakamichi, I
Kitagawa, K
Shirane, M
Tsunematsu, R
Tsukiyama, T
Ishida, N
Kitagawa, M
Nakayama, K
Hatakeyama, S
Citation: K. Nakayama et al., Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication, EMBO J, 19(9), 2000, pp. 2069-2081
Authors:
Mohs, G
Dhanjal, S
Kise, T
Shirane, M
Shimano, R
Svirko, YP
Ohkawa, K
Zheludev, NI
Kuwata-Gonokami, M
Citation: G. Mohs et al., Gigantic reflectance anisotropy of the [110] face of cubic ZnSe in the excitonic part of the spectrum, J PHYS JPN, 69(10), 2000, pp. 3458-3461
Citation: M. Shirane et K. Nakamura, Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP, NEUROPHARM, 39(5), 2000, pp. 866-872
Citation: K. Nakamura et al., Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats, BRAIN RES, 862(1-2), 2000, pp. 266-269
Authors:
Matsusue, T
Akiyama, H
Saiki, T
Ramkumar, C
Shirane, M
Shimano, R
Kuwata-Gonokami, M
Sakaki, H
Citation: T. Matsusue et al., Coherent dynamics of excitons in an island-inserted GaAs/AlAs quantum wellstructure: Suppression of phase relaxation and a deep quantum beat, JPN J A P 1, 38(5A), 1999, pp. 2735-2740
Authors:
Hatakeyama, S
Kitagawa, M
Nakayama, K
Shirane, M
Matsumoto, M
Hattori, K
Higashi, H
Nakano, H
Okumura, K
Onoe, K
Good, RA
Nakayama, K
Citation: S. Hatakeyama et al., Ubiquitin-dependent degradation of I kappa B alpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1, P NAS US, 96(7), 1999, pp. 3859-3863
Authors:
Hatakeyama, S
Kitagawa, M
Nakayama, K
Shirane, M
Matsumoto, M
Hattori, K
Higashi, H
Nakano, H
Okumura, K
Onoe, K
Good, RA
Nakayama, K
Citation: S. Hatakeyama et al., Ubiquitin-dependent degradation of I kappa B alpha is mediated by a ubiquitin ligase Skp1/Cul1/F-box protein FWD1 (vol 96, pg 3859, 1999), P NAS US, 96(11), 1999, pp. 6571-6571
Authors:
Hattori, K
Hatakeyama, S
Shirane, M
Matsumoto, M
Nakayama, K
Citation: K. Hattori et al., Molecular dissection of the interactions among I kappa B alpha, FWD1, and Skp1 required for ubiquitin-mediated proteolysis of I kappa B alpha, J BIOL CHEM, 274(42), 1999, pp. 29641-29647
Authors:
Shirane, M
Hatakeyama, S
Hattori, K
Nakayama, K
Nakayama, K
Citation: M. Shirane et al., Common pathway for the ubiquitination of I kappa B alpha, I kappa B beta, and I kappa B epsilon mediated by the F-box protein FWD1, J BIOL CHEM, 274(40), 1999, pp. 28169-28174
Authors:
Shirane, M
Harumiya, Y
Ishida, N
Hirai, A
Miyamoto, C
Hatakeyama, S
Nakayama, K
Kitagawa, M
Citation: M. Shirane et al., Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing, J BIOL CHEM, 274(20), 1999, pp. 13886-13893
Citation: K. Nakamura et M. Shirane, Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam, EUR J PHARM, 380(2-3), 1999, pp. 81-89